Becton, Dickinson and Company Stock Nyse
Equities
BDXB
US0758874061
Medical Equipment, Supplies & Distribution
Sales 2024 * | 20.25B 27.6B | Sales 2025 * | 21.47B 29.27B | Capitalization | 66.14B 90.15B |
---|---|---|---|---|---|
Net income 2024 * | 2.09B 2.85B | Net income 2025 * | 2.48B 3.38B | EV / Sales 2024 * | 3.91 x |
Net Debt 2024 * | 13.13B 17.9B | Net Debt 2025 * | 10.8B 14.72B | EV / Sales 2025 * | 3.58 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
28.5
x | Employees | 73,000 |
Yield 2024 * |
1.64% | Yield 2025 * |
1.68% | Free-Float | 77.74% |
Latest transcript on Becton, Dickinson and Company
Managers | Title | Age | Since |
---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 08-12-31 |
Director of Finance/CFO | 52 | 21-09-05 | |
Chief Tech/Sci/R&D Officer | 48 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 02-09-23 |
Catherine Burzik
BRD | Director/Board Member | 73 | 13-01-28 |
Director/Board Member | 69 | 10-07-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 104 M€ | -2.20% | - |
1st Jan change | Capi. | |
---|---|---|
-6.44% | 178B | |
-6.08% | 98.95B | |
-9.49% | 44.11B | |
+7.39% | 43.82B | |
+10.10% | 42.74B | |
+11.46% | 28.92B | |
+18.89% | 25.06B | |
-8.71% | 23.38B | |
-12.21% | 21.93B |